SUPPORTING INFORMATION Materials. Unless otherwise noted, all chemicals were obtained from the Aldrich Chemical Company. Synthesis of PiEVE Monomer. Potassium phthalimide (1400 g, 1eq) was suspended in the DMF (5L). The resulting mixture was heated to 93 °C, and then tetrabutylammonium bromide (48.67 g, 0.02 eq) was added. The mixture was stirred for 0.5h. The reaction mixture was cooled to 60~70 °C, and 2-chloroethyl vinyl ether (1006.8 g, 1.25 eq) was added dropwise over 30 min. The reaction mixture was heated to 90~100 °C for 1h. HPLC showed that ~8% potassium phthalimide was remaining. The mixture was cooled to 50~60 °C, and then water (2.0 L) was added dropwise over 1hr. The mixture was cooled to 20~30° C and aged for 30 mins. The mixture was filtered through a Celite pad, the solid was washed with water (2*1 L). The above solids were dissolved in CH2Cl2 (7 L). The solution was concentrated to about 3~4L, until solids appeared. Cyclohexane (5 L) was added dropwise and the mixture was further concentrated to 2~3 L at 45~50 °C. The mixture was cooled to 10~20 °C and stirred for 30 mins. The mixture was filtered through a Celite pad and the cake was washed with cyclohexane (2 L~3 L). The wet cake was dried under vacuum at 40 °C for 12h. The desired product (PiEVE, 1.37 kg) was obtained with 99.87% LCAP (0.13% of alcohol impurity) and 99.6% LCWP in 83.2% corrected yield. 1H NMR (CDCl3, 500 MHz): δ 7.86 (dd, 2H, J = 5.3, 3.0 Hz), 7.72 (dd, 2H, J = 5.4, 3.0 Hz), 6.42 (dd, 1H, J = 14.4, 6.8 Hz), 4.20 (d, 1H, J = 14.4, 2.2 Hz), 4.01 (m, 3H), 3.94 (m, 2H). GC was used to measure residual solvent. The following solvents were present in the following quantities; MeOH <100 ppm, DCM 540 ppm, cyclohexane 320 ppm, 2-chloroethyl vinyl ether <100 ppm and DMF <100 ppm. Purification of Butyl Vinyl Ether. n-Butyl vinyl ether was purchased from Aldrich and contained stabilizer, 0.01% KOH. The peroxide content of butyl vinyl ether was measured prior to distillation and was measured to be <1 ppm (BLD) using QuantofixPeroxide 100 test strips. An NH3-rinsed and oven-dried 2 L, 3-neck round-bottomed flask with magnetic stir bar and internal thermocouple probe was set up in a heating mantle and was fitted with a 14/20 Vigreux column (15 cm), distillation head with water-cooled condenser, and collection flask in a cold bath and purged with nitrogen for 15 min. The flask was charged with butyl vinyl ether (1.50 L). The nitrogen line was moved from the distillation pot to the collection flask and the pot was heated to 100 ºC (internal temperature of 95 ºC) to begin distillation into a dry ice / acetone-cooled collection flask. Fractions (150 – 200 mL, colorless liquid) were collected until <200 mL remained in the pot. Fractions were checked by 1H NMR for purity (CDCl3). Fractions containing large amounts of water, noted by ice crystals in the collection flask, were discarded. Purification of Octadecyl Vinyl Ether. Octadecyl vinyl ether was purchased from TCI. The distillation apparatus was set up behind a blast shield. An ammonia-rinsed 500 mL, 3-neck round-bottomed flask with large magnetic stir bar and internal thermocouple probe was fitted with a 24/40 Vigreux column (30 cm) with distillation head and air-cooled condenser. The flask was set up in a heating mantle. The Coolant (water or air) in condenser should be warmed to room temperature to prevent clogging of distillation equipment. Octadecyl vinyl ether (500 ml) was first warmed to 45 oC to liquefy and this was then charged to the flask. The system was evacuated and purged with nitrogen 3 times to remove air (oxygen). The flask was evacuated (1 mmHg) and heated to 190-195 ºC (internal temperature of 185-190 ºC). The flask was wrapped with glass wool with aluminum foil outside that to contain heat but the Vigreux column was left open to the air to create a better temperature gradient. Fractions were collected until <100 mL remained in the pot. Each fraction was warmed to 40 oC to melt prior to sampling for GC analysis. By GC, the ratio of C18-vinyl ether:C16-vinyl ether >98 : 2 was achieved after distillation. Synthesis of Polymer 1. Synthesis of 18 kDa 15:4:1 [PiEVE:BE:ODVE] by Flow Polymerization. The monomer solution was prepared by dissolving octadecyl vinyl ether (0.734 g, 2.5 mmol, 1 eq), n-butyl vinyl ether (0.99 g, 9.9 mmol, 4 eq) and N-(2-Vinyloxy-ethyl)phthalimide (8.03 g, 37 mmol, 15 eq) dichloromethane (150 mL) with a water content of 100 ppm. The catalyst solution was prepared by dissolving boron trifluoroetherate (0.107 g, 1.5 mol% vs monomers) dichloromethane (5.23 mL) with a water content of 100 ppm. The quench solution was prepared by dissolving 2M ammonia in methanol (1.5 mL, 4 eq versus boron triflouride diethyl etherate) dichloromethane (103 mL). Stream 1 is pumped at 1.429 mL/min through 1/16" PTFE and 316 stainless steel tubing introduced to a controlled bath set at -30 °C. Stream 2 is pumped at 0.0714 mL/min through 1/16" PTFE and 316 stainless steel tubing introduced to the controlled bath. Streams 1 and 2 mix in a 1 mm ID 316 stainless steel tee before entering a 30 mL coil of 1/8" 304 stainless steel tubing. Stream 3 is pumped at 1.429 mL/min through 1/16" PTFE and 316 stainless steel tubing introduced to the controlled bath before mixing with the resulting stream from the 30 mL coil (mixture of Streams 1 and 2) in a 1 mm ID 316 stainless steel tee. The resulting stream exits the controlled bath to a collection vessel. The collected polymer was isolated by removal of dichloromethane under reduced pressure to afford the product Polymer 1 with a molecular weight of Mw = 18.1 kDa and polydispersity index of 1.7. 1H NMR (500 mHz, CDCl ) = δ 7.8-7.6 (om), 3.9-3.0 (om), 1.9-1.1 (om), 1.0-0.7 (om). 3 Synthesis of Polymer 2. Synthesis of 18 kDa 15:4:1 [PiEVE:BE:ODVE] by Batch Polymerization. In a dry 3-neck flask fitted with an overhead stirrer, nitrogen inlet, and temperature probe was charged dichloromethane (112 ml, <10 ppm H2O). The flask was cooled to -40 °C (cryocool bath) then charged BF3-Et2O (1.19 ml, 9.44 mmol). In a separate round bottom flask dissolved n-butyl vinyl ether (48.9 ml, 378 mmol), octadecyl vinyl ether (28 g, 94.0 mmol), and N-(2Vinyloxy-ethyl)phthalimide (308 g, 1416 mmol) in dichloromethane (2100 ml, <10 ppm H2O). The solution of vinyl ether monomers were then charged to the reaction vessel over 1 hr at a constant rate using a Knauer pump. The solution was then let stir for an additional 1 hr and then quenched with NH3 in MeOH (2.0 M, 47 ml) and removed from the cooling bath. Once at room temperature, the reaction mixture was transferred to a recovery flask concentrated in vacuo to yield product Polymer 2 (376 g, 598 mmol, 101% yield) as a foamy white solid with a molecular weight of Mw = 18.3 kDa and polydispersity index of 1.8. 1H NMR (500 mHz, CDCl3) = δ 7.8-7.6 (om), 3.9-3.0 (om), 1.9-1.1 (om), 1.0-0.7 (om). Synthesis of Polymer 3. Synthesis of 27.1 kDa 15:4:1 [PiEVE:BE:ODVE] by Flow Polymerization. The monomer solution was prepared by dissolving octadecyl vinyl ether (6.31 g, 21.27 mmol, 1 eq), n-butyl vinyl ether (8.52 mL, 85.07 mmol, 4 eq) and N-(2-Vinyloxyethyl)phthalimide (69.30 g, 319.02 mmol, 15 eq) in dichloromethane (900 mL) with a water content of 50 ppm. The catalyst solution was prepared by dissolving boron trifluoroetherate (0.92 g, 6.48 mmol, 1.5 mol% vs monomers) and dichloromethane (45 mL) with a water content of 50 ppm. The quench solution was prepared by combining 2M ammonia in methanol (12.96 mL, 25.91 mmol, 4 eq versus boron triflouride diethyl etherate) was dissolved in dichloromethane (887 mL). To generate polymer, stream 1 (monomer solution) was pumped at 1.429 mL/min through 1/16" PTFE and 316 stainless steel tubing introduced into the controlled temperature bath set at -30 °C. Stream 2 (catalyst solution) was pumped at 0.0714 mL/min through 1/16" PTFE and 316 stainless steel tubing introduced into the controlled temperature bath. Streams 1 and 2 were mixed in a 1 mm ID 316 stainless steel tee before entering a 30 mL coil of 1/8" 304 stainless steel tubing. Stream 3 (quench solution) was pumped at 1.429 mL/min through 1/16" PTFE and 316 stainless steel tubing introduced to the controlled bath prior to mixing with the resulting stream from the 30 mL coil (mixture of Streams 1 and 2) in a 1 mm ID 316 stainless steel tee. The resulting stream exited the controlled bath into a collection vessel. The collected polymer was isolated by removal of solvent under reduced pressure to afford the product Polymer 3a with a molecular weight of Mw = 27.1 kDa and polydispersity index of 2.2. 1H NMR (500 mHz, CDCl ) = δ 7.8-7.6 (om), 3.9-3.0 (om), 1.9-1.1 (br), 1.0-0.7 (om). 3 The same procedure was utilized to synthesize two subsequent batches of Polymer 3. Polymer 3b: Mw = 29.4 kDa and polydispersity index of 2.0. 1H NMR (500 mHz, CDCl3) = δ 7.87.6 (om), 3.9-3.0 (om), 1.9-1.1 (om), 1.0-0.7 (om). Polymer 3c: Mw = 28.0 kDa and polydispersity index of 2.8. 1H NMR (500 mHz, CDCl3) = δ 7.87.6 (om), 3.9-3.0 (om), 1.9-1.1 (om), 1.0-0.7 (om). Polymer Deprotection and Purification. In a 3-neck flask fitted with an overhead stirrer, reflux condenser, and nitrogen inlet was slurried Polymer 2 (50.0 g, 79 mmol) in 2-Propanol (1000 mL). Hydrazine (25% wt in H2O) (499 ml, 3889 mmol) was charged to the reaction vessel and the reaction vessel was heated (65 °C). After 16 hrs, the reaction mixture was cooled to room temperature. A constant volume distillation was performed to remove 2-propanol while adding 0.1 M NaOH to maintain a volume of 1500 mL of total reaction volume. The distillation was continued until the amount of 2-propanol remaining in the reaction mixture was below 1 percent of the total volume as monitored by GC. The aqueous polymer solution was then subjected to TFF (tangential flow filtration) purification (PALL centremate membrane, 1K MW cutoff, OS001C12) with NaOH (0.25 N) until the HPLC of the retentate polymer solution indicated complete removal of phthalhydrazide. The TFF process was continued using water until the pH of waste stream (permeate) became neutral (pH 7-8). The aqueous solution was then freeze-dried to obtain the product Polymer 2-deprotected (20.3 g) as a sticky oil. The water content of the isolated polymer was determined by Thermogravimetric Analysis (TGA). The sodium content of the isolated polymer was determined by ICP-MS. The weight percent of the isolated polymer was determined by subtracting the weight of water and sodium hydroxide in the polymer solid from the total weight of polymer solid. 1H NMR (500 mHz, D2O) = δ 3.83.0 (om), 2.8-2.6 (om), 2.0-1.0 (om), 0.9-0.7 (om). All other polymers were deprotected and purified using the same general procedure as that described above. Structure of Amino Low Hex 9 (LH9): 5’-amil-iB-CUAGCUGGACACGUCGAUATsT-iB-3’ (SEQ ID NO.:1) 3’-UsUGAUCGACCUGUGCAGCUAU-5’ (SEQ ID NO.:2) amil = amino linker iB = Inverted deoxy abasic CU = 2’-fluoro (F) AGT = 2’-deoxy UGA = 2’-methoxy (OMe) AU= ribose s= phosphorothioate linkage Structure of Amino Zimmerman ApoB (ZimmApoB): 5’-amil-GGAAUCUUAUAUUUGAUCCAsA-3’ (SEQ ID NO.:3) 3’-UsCsCCUUAGAAUAUAAACUAGGUU-5’ (SEQ ID NO.:4) amil = amino linker UC = 2’-methoxy (OMe) AUG= ribose s= phosphorothioate linkage Sata Modification of Amino Zimmerman ApoB Oligonucleotide. Amino Zimmerman ApoB Oligonucleotide (1g, 0.0714 mmol) was dissolved in 0.1M sodium bicarbonate buffer (20 ml, 50 mg/mL) in a vial with magnetic stir bar and cooled to 0-5 °C in an ice water bath. In a separate vial SATA (83 mg, 0.357 mmol, 5 equivalents; Thermo Scientific part 26102) was dissolved in 0.78 ml DMSO. The SATA solution was added over 1min and the clear, colorless reaction mixture stirred at 0-5 °C for 2h. After 2h, the reaction mixture was sampled and analyzed by HPLC for consumption of the starting oligonucleotide. If the amount of unmodified oligonucleotide was greater than 5 %, then an additional charge of SATA in DMSO (2.0 equivalents) was added and the reaction aged at 0-5 °C for completion of the SATA conjugation (confirmation by HPLC). The reaction mixture was purified by dialysis (MW cutoff and manufacturer information) using endonuclease free water until HPLC indicated the removal of N-hydroxysuccinimide, and N-succinimidyl-S-acetylthioacetate. The recovered solution was lyophilized to afford the product sata-ZimmApoB as a white fluffy solid. Polymer Conjugate Synthesis. Polymer Polymer 2-deprotected (1.2 g) was placed in a 40 mL vial and was dissolved in 100 mM sterile TRIS buffer at pH 9 (120 mL, 10 mg/mL) and added to a 1 L sterile plastic bottle. To this solution was added SMPT (Thermo Scientific, ) as 1 mg/mL solution in dmso (18 mg, 1800 uL) corresponding to 1.5 wt% with respect to the polymer weight. The solution was stirred for 1 hr at rt to generate activated polymer. The activated polymer solution was further diluted using 100 mM sterile TRIS buffer at pH 9 (496 mL), followed by the addition of sata-modified siRNA sata-ZimmApoB as a solution in water (250 mg, 32.4 mg/mL, 7716 uL). This solution was aged for 4 hours at room temperature to generate the siRNA-polymer conjugate. In a separate 1 L sterile plastic bottle, solid CDM-NAG (5.5 g) and CDM-PEG (2.85 g) was added. The siRNA-polymer conjugate solution was transferred by pouring into the plastic bottle containing the CDM-NAG and CDM-PEG solids. The mixture was stirred for 2 minutes to dissolve all solids and then transferred by pouring into the original plastic bottle which contained the siRNA-polymer conjugate. The reaction was stirred for 1 hour to generate the product masked siRNA-polymer conjugate. The pH of the final solution was monitored to ensure the pH was 8-9 throughout the conjugation process. Purification of the masked polyconjugate was performed using a tangential flow filtration (TFF) purification process (get information from Sergey’s group). The amount of RNA covalently attached to poly(vinyl ether) polymers (conjugation efficiency) was determined using strong anion exchange chromatography (SAX). The conjugation efficiency of the product 2a’ was measured as 89% by SAX (see Figure 10 and conjugation efficiency assay details for further information). The percentage of amines in a poly(vinyl ether) polymer that are covalently modified with disubstituted maleimides CDM-NAG and CDM-PEG (molar basis) was determined by HPLC (masking efficiency). The masking efficiency of the product 2a’ was measured as 50% (see masking efficiency assay for further details). The RNA concentration in the product 2a’ was measured using ICP and this concentration was used in determining dilutions/dosage volumes for in vivo studies. Masked Polymer Conjugate Purification Process. Tangential flow filtration (TFF) process was used to purify masked polymer conjugate formulations (i.e. 2a’) of un-incorporated components and to exchange buffer to pharmaceutically acceptable formulation vehicle. The TFF filter material was made of either modified polyethersulfone (PES) or regenerated cellulose. The selection of molecular weight cutoff for these membranes was done with efficiency of purification and retention of polymer conjugate in mind. The processing parameters, including but not limited to feed pressure, retentate pressure, crossflow rate and filtrate flux were set to allow reproducibility from batch to batch and linear scaling of the process. Using the difiltration mode of TFF, the reaction impurities were filtered out into the permeate while the retained polymer conjugate underwent a buffer exchange. After TFF, the final product was concentrated to 0.4-2.0 mg/ml of siRNA and sterile filtered using a 0.2μm PES syringe filter and stored at -20 °C until use. Proton NMR. The 1H and spectra were recorded on a Bruker AV or DPX series NMR spectrometer at a frequency of 400 MHz or 500 MHz as noted, and are internally referenced to residual HOD at 4.80?ppm, CHD2Cl2 at 5.32ppm or CHCl3 at 7.27 ppm. Data for 1H NMR are reported as follows: chemical shift (δ), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, o= overlapped, ) integration and coupling constant (Hz). 1H NMR spectra were in full accordance with the expected structures. Determination of Monomer Ratio for Deprotected Polymer: H2 C OY H2 C H2 C OX CH CH CH O O O CH2 Y = any monomer H2C H2C (a) CH2 CH2 H2C CH2 ND2 H3C X = H, CH3 CH2 (H2C)14 (c) (b) H3C 5a + 3b + 3c = (CH/CH2, broad integral region from ~ 4.0-2.4 ppm) a + 3b + 17c = (1/2CH2, broad integral region from ~ 2.0-1.0 ppm) b + c = (1/3CH3, broad integral region from ~1.0-0.2 ppm) Molecular Weight Determination Using SEC (Size Exclusion Chromatography). Polymer molecular weight determination for protected polymers was performed on an Agilent 1100 high performance liquid chromatograph (HPLC) coupled with a Wyatt miniDAWN™ TREOS (3 angle multi angle light scattering (MALS) system) and a Wyatt Optilab® T-rEX (refractive index detector). Chromatography was performed using two size exclusion chromatographic columns in tandem, Waters Styragel HR3 Column, 5 um, 7.8 x 300 mm (THF) and Waters Styragel HR4E Column, 5 um, 7.8 x 300 mm (THF) with 100% THF as mobile phase at a flow rate of 1.0 mL/min. The temperature of the column was set at 25 °C and the UV detection wavelength was 260 nm. The polymer sample was dissolved in THF at 1-10 mg/mL and 0.5 mg material was injected. Instrument normalization and calibration was performed using 2-40K polystyrene standards with a PDI of less than 1.1 (purchased from Polymer Laboratories). No calibration standards were used in determination of molecular weights or polydispersities. The dn/dc values were obtained for each injection assuming 100% mass elution from the columns. These values were also independently verified by measuring the dn/dc independently using a Wyatt Optilab® T-rEX refractometer. The data was collected and processed using Wyatt Astra software. Deprotected polymer molecular weight was not measured directly. Deprotected molecular weight values were calculated by adjusting the corresponding protected molecular weight based on the mass loss due to removal of the protecting group. Conjugation Efficiency (siRNA-polymer conjugation) The strong anion exchange assay (SAX assay) is used to determine the conjugation efficiency by analyzing the final masked polyconjugate with and without dithiothreitol (DTT) treatment. Chromatographic Conditions Column: Proteomix SAX-NP3 Column (Sepax Technologies), 3.0 m, 100 mm x 4.6 mm Column Temperature: RT Flow Rate: 0.4 mL/min Detection: CAD and UV UV = 260 nm, 234 nm and 343 nm (optional) Injection Volume: 10 L Run Time: 35 min Mobile Phase: A: 100 mM Tris, 10% Acetonitrile, pH8.0 B: 100 mM Tris, 10% Acetonitrile, 2 M LiCl, pH8.0 Mobile Phase Program: Time (min) A% B% 0 5 30 35 100% 100% 40% 0% 0% 0% 60% 100% Equilibrate column for 5 min Preparation of Solutions Poly Conjugate: Inject as-is at 10 ul DTT Treatment: equal volume of conjugate with 1.0M DTT, inject at 20 ul, DTT solution: 1.0 M in DI water Free RNA duplex as well as free RNA duplex-dimer was visualized using SAX chromatography. Total RNA (both free and bound) was determined by using Inductively Coupled Plasma (ICP) spectroscopy. Since the RNA is the only phosphorus containing species in the formulations, determining the total phosphorus content can be used to directly determine the total RNA concentration. Once the free RNA (duplex and duplex-dimer) and total RNA is determined, the amount of RNA conjugated to the polymer can be calculated (i.e. conjugation efficiency). Total RNA (bound and unbound RNA and RNA dimer) can also be determined and visualized by pre-treatment of the polyconjugate with DTT prior to SAX chromatography. Conjugation efficiencies are reported for all poly(vinyl ether) polymer conjugates in the text of the paper. Masking Efficiency Total concentrations of CDM-NAG and CDM-PEG were determined using reversephase HPLC (UV at a wavelength of 260 nm) with mobile phases of 0.1% TFA in water and 0.1% TFA in 70/30 methanol:acetonitrile. Rapid demasking of the polymer after injection onto the column allows quantitation of CDMs with the polymer removed using a C18 guard column to prevent chromatographic interference. Free (i.e. unbound) CDM-NAG and CDM-PEG is analyzed by first filtering through a 10K centrifuge filter followed by analysis of the permeate using the same reverse-phase HPLC method. Masking efficiency can be calculated by first calculating the bound RNA, CDM-NAG and CDM-PEG. The polymer molecular weight in combination with the total amines available for conjugation is then used with the bound ligands to calculate masking efficiency. Masking efficiencies are reported for all poly(vinyl ether) polymer conjugates in table 3. In Vivo Evaluation of Efficacy in Mice CD1 mice were tail vein injected with the siRNA containing polymer conjugates at a specified dose (mg/kg) in a volume of 0.2 mL, 100mM TRIS/9% glucose, pH9, vehicle. Fortyeight hours post dose, mice were sacrificed and liver tissue samples were immediately preserved in RNALater (Ambion). Preserved liver tissue was homogenized and total RNA isolated using a Qiagen bead mill and the Qiagen miRNA-Easy RNA isolation kit following the manufacturer's instructions. Liver ApoB mRNA levels were determined by quantitative RT-PCR. Message was amplified from purified RNA utilizing primers against the mouse ApoB mRNA (Applied Biosystems Cat. No. Mm01545156_m1). The PCR reaction was run on an ABI 7500 instrument with a 96-well Fast Block. The ApoB mRNA level is normalized to the housekeeping PPIB mRNA and GAPDH. PPIB and GAPDH mRNA levels were determined by RT-PCR using a commercial probe set (Applied Biosytems Cat. No. Mm00478295_m1 and Mm4352339E_m1). Results are expressed as a ratio of ApoB mRNA/ PPIB / GAPDH mRNA. All mRNA data is expressed relative to the vehicle control.